Eva Baecklund

Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland

Wiley, Mandi M.; Radziszewski, Marcin; Khatri, Bhuwan; Joachims, Michelle L. et al.

Ingår i Annals of the Rheumatic Diseases, s. 1512-1527, 2025

• DOI för Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland

Targeted proteomics identifies differentially expressed proteins in Sjögren's disease with incident lymphoma

Imgenberg-Kreuz, Juliana; Fugmann, Cecilia; Molin, Anna-Maja; Backlin, Carin et al.

Ingår i RMD Open, 2025

• DOI för Targeted proteomics identifies differentially expressed proteins in Sjögren's disease with incident lymphoma
• Ladda ner fulltext (pdf) av Targeted proteomics identifies differentially expressed proteins in Sjögren's disease with incident lymphoma

A high polygenic risk score is associated with SSA/SSB antibody positivity and early onset in primary Sjögren’s disease

Fugmann, Cecilia; Reid, Sarah; Pucholt, Pascal; Kvarnström, Marika et al.

Ingår i Rheumatology, s. 4341-4346, 2025

• DOI för A high polygenic risk score is associated with SSA/SSB antibody positivity and early onset in primary Sjögren’s disease
• Ladda ner fulltext (pdf) av A high polygenic risk score is associated with SSA/SSB antibody positivity and early onset in primary Sjögren’s disease

Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13

Euler, Nora; Hellbacher, Erik; af Klint, Erik; Hansson, Monika et al.

Ingår i Clinical Immunology, 2025

• DOI för Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13
• Ladda ner fulltext (pdf) av Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13

Unraveling the Genetics of Shared Clinical and Serological Manifestations in Patients With Systemic Inflammatory Autoimmune Diseases

Bianchi, Matteo; Kozyrev, Sergey V.; Notarnicola, Antonella; Sandling, Johanna K. et al.

Ingår i Arthritis & Rheumatology, s. 212-225, 2025

• DOI för Unraveling the Genetics of Shared Clinical and Serological Manifestations in Patients With Systemic Inflammatory Autoimmune Diseases
• Ladda ner fulltext (pdf) av Unraveling the Genetics of Shared Clinical and Serological Manifestations in Patients With Systemic Inflammatory Autoimmune Diseases

Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland

Wiley, Mandi M.; Radziszewski, Marcin; Khatri, Bhuwan; Joachims, Michelle L. et al.

Ingår i Annals of the Rheumatic Diseases, s. 1512-1527, 2025

• DOI för Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland

Targeted proteomics identifies differentially expressed proteins in Sjögren's disease with incident lymphoma

Imgenberg-Kreuz, Juliana; Fugmann, Cecilia; Molin, Anna-Maja; Backlin, Carin et al.

Ingår i RMD Open, 2025

• DOI för Targeted proteomics identifies differentially expressed proteins in Sjögren's disease with incident lymphoma
• Ladda ner fulltext (pdf) av Targeted proteomics identifies differentially expressed proteins in Sjögren's disease with incident lymphoma

A high polygenic risk score is associated with SSA/SSB antibody positivity and early onset in primary Sjögren’s disease

Fugmann, Cecilia; Reid, Sarah; Pucholt, Pascal; Kvarnström, Marika et al.

Ingår i Rheumatology, s. 4341-4346, 2025

• DOI för A high polygenic risk score is associated with SSA/SSB antibody positivity and early onset in primary Sjögren’s disease
• Ladda ner fulltext (pdf) av A high polygenic risk score is associated with SSA/SSB antibody positivity and early onset in primary Sjögren’s disease

Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13

Euler, Nora; Hellbacher, Erik; af Klint, Erik; Hansson, Monika et al.

Ingår i Clinical Immunology, 2025

• DOI för Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13
• Ladda ner fulltext (pdf) av Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13

Unraveling the Genetics of Shared Clinical and Serological Manifestations in Patients With Systemic Inflammatory Autoimmune Diseases

Bianchi, Matteo; Kozyrev, Sergey V.; Notarnicola, Antonella; Sandling, Johanna K. et al.

Ingår i Arthritis & Rheumatology, s. 212-225, 2025

• DOI för Unraveling the Genetics of Shared Clinical and Serological Manifestations in Patients With Systemic Inflammatory Autoimmune Diseases
• Ladda ner fulltext (pdf) av Unraveling the Genetics of Shared Clinical and Serological Manifestations in Patients With Systemic Inflammatory Autoimmune Diseases

Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritis

Sysojev, Anton Öberg; Saevarsdottir, Saedis; Diaz-Gallo, Lina-Marcela; Silberberg, Gilad N. et al.

Ingår i Rheumatology, s. 1221-1229, 2024

• DOI för Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritis
• Ladda ner fulltext (pdf) av Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritis

Trigger finger - Poor outcome of surgery associated with younger age, pain, psoriatic arthritis and atopic disease.

Holm, Björn; Rönnelid, Johan; Baecklund, Eva; Wiig, Monica

Ingår i Upsala Journal of Medical Sciences, 2024

• DOI för Trigger finger - Poor outcome of surgery associated with younger age, pain, psoriatic arthritis and atopic disease.
• Ladda ner fulltext (pdf) av Trigger finger - Poor outcome of surgery associated with younger age, pain, psoriatic arthritis and atopic disease.

Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of ORAL Surveillance

Karpouzas, George A.; Szekanecz, Zoltan; Baecklund, Eva; Mikuls, Ted R. et al.

Ingår i Therapeutic Advances in Musculoskeletal Disease, 2023

• DOI för Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of ORAL Surveillance
• Ladda ner fulltext (pdf) av Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of ORAL Surveillance

Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme

Frisell, Thomas; Bower, Hannah; Morin, Matilda; Baecklund, Eva et al.

Ingår i Annals of the Rheumatic Diseases, s. 601-610, 2023

• DOI för Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme
• Ladda ner fulltext (pdf) av Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme

Strong Association of Combined Genetic Deficiencies in the Classical Complement Pathway With Risk of Systemic Lupus Erythematosus and Primary Sjögren's Syndrome

Lundtoft, Christian; Sjöwall, Christopher; Rantapää‐Dahlqvist, Solbritt; Bengtsson, Anders A. et al.

Ingår i Arthritis & Rheumatology, s. 1842-1850, 2022

• DOI för Strong Association of Combined Genetic Deficiencies in the Classical Complement Pathway With Risk of Systemic Lupus Erythematosus and Primary Sjögren's Syndrome
• Ladda ner fulltext (pdf) av Strong Association of Combined Genetic Deficiencies in the Classical Complement Pathway With Risk of Systemic Lupus Erythematosus and Primary Sjögren's Syndrome

Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity

Hellbacher, Erik; Sundström, Christer; Molin, Daniel; Baecklund, Eva et al.

Ingår i Cancers, 2022

• DOI för Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity
• Ladda ner fulltext (pdf) av Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity

Genome-wide association study of liver enzyme elevation in an extended cohort of rheumatoid arthritis patients starting low-dose methotrexate

Cavalli, Marco; Eriksson, Niclas; Karlsson Sundbaum, Johanna; Wallenberg, Matilda et al.

Ingår i Pharmacogenomics (London), s. 813-820, 2022

• DOI för Genome-wide association study of liver enzyme elevation in an extended cohort of rheumatoid arthritis patients starting low-dose methotrexate
• Ladda ner fulltext (pdf) av Genome-wide association study of liver enzyme elevation in an extended cohort of rheumatoid arthritis patients starting low-dose methotrexate

Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study

Cordtz, Rene Lindholm; Askling, Johan; Delcoigne, Benedicte; Smedby, Karin E. et al.

Ingår i RMD Open, 2022

• DOI för Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study
• Ladda ner fulltext (pdf) av Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study

Complement C4 Copy Number Variation is Linked to SSA/Ro and SSB/La Autoantibodies in Systemic Inflammatory Autoimmune Diseases

Lundtoft, Christian; Pucholt, Pascal; Martin, Myriam; Bianchi, Matteo et al.

Ingår i Arthritis & Rheumatology, s. 1440-1450, 2022

• DOI för Complement C4 Copy Number Variation is Linked to SSA/Ro and SSB/La Autoantibodies in Systemic Inflammatory Autoimmune Diseases
• Ladda ner fulltext (pdf) av Complement C4 Copy Number Variation is Linked to SSA/Ro and SSB/La Autoantibodies in Systemic Inflammatory Autoimmune Diseases

Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset

Saevarsdottir, Saedis; Stefansdottir, Lilja; Sulem, Patrick; Thorleifsson, Gudmar et al.

Ingår i Annals of the Rheumatic Diseases, s. 1085-1095, 2022

• DOI för Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset
• Ladda ner fulltext (pdf) av Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset

Genome-wide association study identifies Sjogren's risk loci with functional implications in immune and glandular cells

Khatri, Bhuwan; Tessneer, Kandice L.; Rasmussen, Astrid; Aghakhanian, Farhang et al.

Ingår i Nature Communications, 2022

• DOI för Genome-wide association study identifies Sjogren's risk loci with functional implications in immune and glandular cells
• Ladda ner fulltext (pdf) av Genome-wide association study identifies Sjogren's risk loci with functional implications in immune and glandular cells

Does being exposed to an educational tool influence patient preferences?: The influence of an educational tool on patient preferences assessed by a discrete choice experiment

Schölin Bywall, Karin; Veldwijk, Jorien; Hansson, Mats G.; Baecklund, Eva et al.

Ingår i Patient Education and Counseling, s. 2577-2585, 2021

• DOI för Does being exposed to an educational tool influence patient preferences?: The influence of an educational tool on patient preferences assessed by a discrete choice experiment

Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision

Bower, Hannah; Frisell, Thomas; di Giuseppe, Daniela; Delcoigne, Bénédicte et al.

Ingår i RMD Open, 2021

• DOI för Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision
• Ladda ner fulltext (pdf) av Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision

Genome-wide association study of liver enzyme elevation in rheumatoid arthritis patients starting methotrexate

Karlsson Sundbaum, Johanna; Baecklund, Eva; Eriksson, Niclas; Kohnke, Hugo et al.

Ingår i Pharmacogenomics (London), s. 973-982, 2021

• DOI för Genome-wide association study of liver enzyme elevation in rheumatoid arthritis patients starting methotrexate
• Ladda ner fulltext (pdf) av Genome-wide association study of liver enzyme elevation in rheumatoid arthritis patients starting methotrexate

Tuberculosis in biologic-naïve patients with rheumatoid arthritis: risk factors and tuberculosis characteristics

Karlsson Sundbaum, Johanna; Arkema, Elizabeth V.; Bruchfeld, Judith; Jonsson, Jerker et al.

Ingår i Journal of Rheumatology, s. 1243-1250, 2021

• DOI för Tuberculosis in biologic-naïve patients with rheumatoid arthritis: risk factors and tuberculosis characteristics

Genetic and clinical basis for two distinct subtypes of primary Sjögren's syndrome

Thorlacius, Guðný Ella; Hultin-Rosenberg, Lina; Sandling, Johanna K.; Bianchi, Matteo et al.

Ingår i Rheumatology, s. 837-848, 2021

• DOI för Genetic and clinical basis for two distinct subtypes of primary Sjögren's syndrome
• Ladda ner fulltext (pdf) av Genetic and clinical basis for two distinct subtypes of primary Sjögren's syndrome

Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study

Bower, Hannah; Frisell, Thomas; Di Giuseppe, Daniela; Delcoigne, Benedicte et al.

Ingår i Annals of the Rheumatic Diseases, s. 1086-1093, 2021

• DOI för Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study
• Ladda ner fulltext (pdf) av Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study

Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs: a Swedish cohort study of risks by time, drug and lymphoma subtype

Hellgren, Karin; Di Giuseppe, Daniela; Smedby, Karin E.; Sundström, Christer et al.

Ingår i Rheumatology, s. 809-819, 2021

• DOI för Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs: a Swedish cohort study of risks by time, drug and lymphoma subtype

Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden

Sima, Andreea; Hollander, Peter; Baecklund, Eva; Smedby, Karin E. et al.

Ingår i British Journal of Haematology, s. 568-579, 2021

• DOI för Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden
• Ladda ner fulltext (pdf) av Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden

Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders

Kinch, Amelie; Baecklund, Eva; Molin, Daniel; Pauksen, Karlis et al.

Ingår i Acta Oncologica, s. 771-778, 2021

• DOI för Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders
• Ladda ner fulltext (pdf) av Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders

Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial

Hetland, Merete Lund; Haavardsholm, Espen A.; Rudin, Anna; Nordstrom, Dan et al.

Ingår i The BMJ, 2020

• DOI för Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial
• Ladda ner fulltext (pdf) av Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial

Increased risk of multiple myeloma in primary Sjogren's syndrome is limited to individuals with Ro/SSA and La/SSB autoantibodies

Mofors, Johannes; Björk, Albin; Smedby, Karin E.; Kvarnström, Marika et al.

Ingår i Annals of the Rheumatic Diseases, s. 307-308, 2020

• DOI för Increased risk of multiple myeloma in primary Sjogren's syndrome is limited to individuals with Ro/SSA and La/SSB autoantibodies

Patient preferences on rheumatoid arthritis second-line treatment: a discrete choice experiment of Swedish patients

Schölin Bywall, Karin; Kihlbom, Ulrik; Hansson, Mats; Falahee, Marie et al.

Ingår i Arthritis Research & Therapy, 2020

• DOI för Patient preferences on rheumatoid arthritis second-line treatment: a discrete choice experiment of Swedish patients
• Ladda ner fulltext (pdf) av Patient preferences on rheumatoid arthritis second-line treatment: a discrete choice experiment of Swedish patients

Population-based study of patients with primary Sjögren's syndrome and lymphoma: lymphoma subtypes, clinical characteristics, and gender differences

Vasaitis, Lilian; Nordmark, Gunnel; Theander, E; Backlin, Carin et al.

Ingår i Scandinavian Journal of Rheumatology, s. 225-232, 2020

• DOI för Population-based study of patients with primary Sjögren's syndrome and lymphoma: lymphoma subtypes, clinical characteristics, and gender differences

MTHFR, TYMS and SLCO1B1 polymorphisms and adverse liver effects of methotrexate in rheumatoid arthritis

Karlsson Sundbaum, Johanna; Baecklund, Eva; Eriksson, Niclas; Hallberg, Pär et al.

Ingår i Pharmacogenomics (London), s. 337-346, 2020

• DOI för MTHFR, TYMS and SLCO1B1 polymorphisms and adverse liver effects of methotrexate in rheumatoid arthritis

Malignant lymphoma in granulomatosis with polyangiitis: subtypes, clinical characteristics and prognosis

Hellbacher, Erik; Hjorton, Karin; Backlin, Carin; Enblad, Gunilla et al.

Ingår i Acta Oncologica, s. 1655-1659, 2019

• DOI för Malignant lymphoma in granulomatosis with polyangiitis: subtypes, clinical characteristics and prognosis

Comparison of patients with and without pre-existing lymphoma at diagnosis of primary Sjögren's syndrome

Vasaitis, Lilian; Nordmark, Gunnel; Theander, E; Backlin, Carin et al.

Ingår i Scandinavian Journal of Rheumatology, s. 207-212, 2019

• DOI för Comparison of patients with and without pre-existing lymphoma at diagnosis of primary Sjögren's syndrome
• Ladda ner fulltext (pdf) av Comparison of patients with and without pre-existing lymphoma at diagnosis of primary Sjögren's syndrome

Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long-term follow-up of predictors, surveillance, and outcome in clinical practice

Karlsson Sundbaum, Johanna; Eriksson, Niclas; Hallberg, Pär; Lehto, Niklas et al.

Ingår i INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, s. 1226-1232, 2019

• DOI för Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long-term follow-up of predictors, surveillance, and outcome in clinical practice
• Ladda ner fulltext (pdf) av Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long-term follow-up of predictors, surveillance, and outcome in clinical practice

Cell of origin in diffuse large B-cell lymphoma in systemic lupus erythematosus: molecular and clinical factors associated with survival

Tessier-Cloutier, Basile; Twa, David D. W.; Baecklund, Eva; Gascoyne, Randy et al.

Ingår i Lupus Science and Medicine, 2019

• DOI för Cell of origin in diffuse large B-cell lymphoma in systemic lupus erythematosus: molecular and clinical factors associated with survival
• Ladda ner fulltext (pdf) av Cell of origin in diffuse large B-cell lymphoma in systemic lupus erythematosus: molecular and clinical factors associated with survival

Autoimmune disease in patients with diffuse large B-cell lymphoma: occurrence and impact on outcome

Mörth, Charlott; Valachis, Antonios; Sabaa, Amal Abu; Marshall, Katharina et al.

Ingår i Acta Oncologica, s. 1170-1177, 2019

• DOI för Autoimmune disease in patients with diffuse large B-cell lymphoma: occurrence and impact on outcome

Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation

Kinch, Amelie; Sundström, Christer; Baecklund, Eva; Backlin, Carin et al.

Ingår i Leukemia and Lymphoma, s. 376-384, 2019

• DOI för Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation
• Ladda ner fulltext (pdf) av Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation

Genetic basis and clinical evidence for two variants of primary Sjögren's syndrome with distinct outcomes

Thorlacius, Gudny Ella; Hultin-Rosenberg, Lina; Sandling, Johanna K.; Imgenberg-Kreuz, Juliana et al.

Ingår i Clinical and Experimental Rheumatology, 2018

Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis

Baecklund, Eva; Backlin, Carin; Rönnelid, Johan; Toes, R et al.

Ingår i Scandinavian Journal of Rheumatology, s. 270-275, 2018

• DOI för Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis

Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: a long-term follow-up of occurrence, predictors, surveillance, and outcome in clinical practice

Sundbaum, J. K.; Ericsson, N.; Hallberg, Pär; Lehto, N. et al.

Ingår i Annals of the Rheumatic Diseases, s. 977-977, 2018

• DOI för Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: a long-term follow-up of occurrence, predictors, surveillance, and outcome in clinical practice

An Analysis of Cell-of-Origin in Diffuse Large B-Cell Lymphoma in Systemic Lupus Erythematosus, Including Molecular and Clinical Factors Associated with Survival

Tessier-Cloutier, Basile; Twa, David; Baecklund, Eva; Gascoyne, Randy et al.

Ingår i Arthritis & Rheumatology, 2018

Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics

Frisell, Thomas; Baecklund, Eva; Bengtsson, Karin; Di Giuseppe, Daniela et al.

Ingår i Annals of the Rheumatic Diseases, s. 650-657, 2018

• DOI för Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics
• Ladda ner fulltext (pdf) av Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics

Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project

Mercer, Louise K.; Regierer, Anne C.; Mariette, Xavier; Dixon, William G. et al.

Ingår i Annals of the Rheumatic Diseases, s. 2025-2030, 2017

• DOI för Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project
• Ladda ner fulltext (pdf) av Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project

Confounding By Indication Will Make Non-Tnfi Bdmards Appear More Harmful Than Tnfi Bdmards A Nationwide Study Of Channeling In Sweden 2010-2014

Frisell, T.; Baecklund, Eva; Bengtsson, K.; Di Giuseppe, D. et al.

Ingår i Annals of the Rheumatic Diseases, s. 134-135, 2017

• DOI för Confounding By Indication Will Make Non-Tnfi Bdmards Appear More Harmful Than Tnfi Bdmards A Nationwide Study Of Channeling In Sweden 2010-2014

Malignant Lymphoma In Granulomatosis With Polyangiitis

Hellbacher, Erik; Hjorton, Karin; Sundström, Christer; Baecklund, Eva et al.

Ingår i Rheumatology, 2017

Rheumatoid Arthritis and Risk of Malignant Lymphoma - Is the risk still increased?

Hellgren, K.; Baecklund, Eva; Backlin, Carin; Sundström, Christer et al.

Ingår i Arthritis & Rheumatology, s. 700-708, 2017

• DOI för Rheumatoid Arthritis and Risk of Malignant Lymphoma - Is the risk still increased?

Long-term follow-up in primary Sjögren's syndrome reveals differences in clinical presentation between female and male patients

Sepulveda, Jorge I. Ramirez; Kvarnstrom, Marika; Eriksson, Per; Mandl, Thomas et al.

Ingår i Biology of Sex Differences, 2017

• DOI för Long-term follow-up in primary Sjögren's syndrome reveals differences in clinical presentation between female and male patients
• Ladda ner fulltext (pdf) av Long-term follow-up in primary Sjögren's syndrome reveals differences in clinical presentation between female and male patients

Population-based experience on primary central nervous system lymphoma 2000-2012: the incidence is increasing

Enblad, Gunilla; Martinsson, Gustaf; Baecklund, Eva; Hesselager, Göran et al.

Ingår i Acta Oncologica, s. 599-607, 2017

• DOI för Population-based experience on primary central nervous system lymphoma 2000-2012: the incidence is increasing

Cell of Origin (COO) of Diffuse Large B-Cell Lymphoma (DLBCL) in Patients with Systemic Lupus Erythematosus (SLE)

Tessier-Cloutier, Basile; Bernatsky, Sasha; Baecklund, Eva; Gascoyne, Randy et al.

Ingår i Laboratory Investigation, 2017

Cell of Origin (COO) of Diffuse Large B-Cell Lymphoma (DLBCL) in Patients with Systemic Lupus Erythematosus (SLE)

Tessier-Cloutier, Basile; Bernatsky, Sasha; Baecklund, Eva; Gascoyne, Randy et al.

Ingår i Modern Pathology, 2017

• DOI för Cell of Origin (COO) of Diffuse Large B-Cell Lymphoma (DLBCL) in Patients with Systemic Lupus Erythematosus (SLE)

Primary Sjögren's Syndrome and Lymphoma – A Population-Based Study Focused on Lymphoma as Exclusion Criterion for Primary Sjögren's Syndrome Diagnosis

Vasaitis, Lilian; Nordmark, Gunnel; Theander, E.; Backlin, Carin et al.

Ingår i Annals of the Rheumatic Diseases, s. 779-780, 2016

• DOI för Primary Sjögren's Syndrome and Lymphoma – A Population-Based Study Focused on Lymphoma as Exclusion Criterion for Primary Sjögren's Syndrome Diagnosis

Sporadic occurrence of non-diagnosed IgG4-related disease in lymphoma patients with a previous Sjögren's syndrome diagnosis.

Vasaitis, Lilian; Sundström, Christer; Backlin, Carin; Nordmark, Gunnel et al.

Ingår i Acta Oncologica, s. 1139-1144, 2016

• DOI för Sporadic occurrence of non-diagnosed IgG4-related disease in lymphoma patients with a previous Sjögren's syndrome diagnosis.

Sporadic Occurrence of Non-Diagnosed IgG4-Related Disease in Lymphoma Patients with a Previous Sjogren's Syndrome Diagnosis

Vasaitis, Lilian; Sundström, Christer; Backlin, Carin; Nordmark, Gunnel et al.

Ingår i Scandinavian Journal of Immunology, s. 407-407, 2015

How good is the coverage and how accurate are exposure data in the Swedish Biologics Register (ARTIS)?

Wadström, H; Eriksson, J K; Neovius, M; Askling, J et al.

Ingår i Scandinavian Journal of Rheumatology, 2015

• DOI för How good is the coverage and how accurate are exposure data in the Swedish Biologics Register (ARTIS)?

Cell of Origin of Diffuse Large B-Cell Lymphoma (DLBCL) in Patients with Systemic Lupus Erythematosus (SLE)

Cloutier, Basile Tessier; Farinha, Pedro; Bernatsky, Sasha; Baecklund, Eva et al.

Ingår i Arthritis & Rheumatology, 2015

• DOI för Cell of Origin of Diffuse Large B-Cell Lymphoma (DLBCL) in Patients with Systemic Lupus Erythematosus (SLE)

First Results Of A European Registries Collaborative Project To Describe The Spectrum Of Lymphomas Across Different Drug Treatment Groups In Rheumatoid Arthritis

Mercer, Louise; Mariette, Xavier; Dixon, Will; Baecklund, Eva et al.

Ingår i Rheumatology, s. 25-25, 2015

Lymphoma in Patients with Granulomatosis with Polyangiitis

Hjorton, Karin; Hellbacher, Erik; Sundstrom, Christer; Baecklund, Eva et al.

Ingår i Arthritis & Rheumatology, 2015

• DOI för Lymphoma in Patients with Granulomatosis with Polyangiitis

Lymphoma in Patients with Rheumatoid Arthritis Treated with Biologic Drugs: Long-Term Follow-up of Risks and Lymphoma Subtypes

Hellgren, Karin; Sundstrom, Christer; Askling, Johan; Baecklund, Eva

Ingår i Arthritis & Rheumatology, 2015

• DOI för Lymphoma in Patients with Rheumatoid Arthritis Treated with Biologic Drugs: Long-Term Follow-up of Risks and Lymphoma Subtypes

Reduced expression of TRIM21/Ro52 predicts poor prognosis in diffuse large B-cell lymphoma patients with and without rheumatic disease

Brauner, S.; Zhou, W.; Backlin, Carin; Green, T. M. et al.

Ingår i Journal of Internal Medicine, s. 323-332, 2015

• DOI för Reduced expression of TRIM21/Ro52 predicts poor prognosis in diffuse large B-cell lymphoma patients with and without rheumatic disease

Leukemia and Myelodysplastic Syndrome in Granulomatosis with Polyangiitis: Subtypes, Clinical Characteristics, and Outcome

Knight, Ann; Hjorton, Karin; Sundström, Christer; Höglund, Martin et al.

Ingår i Journal of Rheumatology, s. 690-694, 2015

• DOI för Leukemia and Myelodysplastic Syndrome in Granulomatosis with Polyangiitis: Subtypes, Clinical Characteristics, and Outcome

Expression of Intratumoral Forkhead Box Protein 3 in Posttransplant Lymphoproliferative Disorders: Clinical Features and Survival Outcomes

Berglund, David; Kinch, Amelie; Edman, Elin; Backlin, Carin et al.

Ingår i Transplantation, s. 1036-1042, 2015

• DOI för Expression of Intratumoral Forkhead Box Protein 3 in Posttransplant Lymphoproliferative Disorders: Clinical Features and Survival Outcomes

Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?

Arkema, Elizabeth V; Jonsson, Jerker; Baecklund, Eva; Bruchfeld, Judith et al.

Ingår i Annals of the Rheumatic Diseases, s. 1212-1217, 2015

• DOI för Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?

Ankylosing Spondylitis, Psoriatic Arthritis, and Risk of Malignant Lymphoma: A Cohort Study Based on Nationwide Prospectively Recorded Data From Sweden

Hellgren, K.; Smedby, K. E.; Backlin, Carin; Sundström, Christer et al.

Ingår i Arthritis & Rheumatology, s. 1282-1290, 2014

• DOI för Ankylosing Spondylitis, Psoriatic Arthritis, and Risk of Malignant Lymphoma: A Cohort Study Based on Nationwide Prospectively Recorded Data From Sweden

Comparison of lymphomas in primary and secondary Sjogren's syndrome

Vasaitis, Lilian; Nordmark, Gunnel; Askling, J.; Ekstrom-Smedby, K. et al.

Ingår i Scandinavian Journal of Rheumatology, s. 83-83, 2014

Methotrexate in rheumatoid arthritis and psoriasis/psoriatic arthritis: a comparative study of hepatotoxicity

Sundbaum Karlsson, Johanna; Berglund, V.; Back, Johan; Lehto, N. et al.

Ingår i Scandinavian Journal of Rheumatology, s. 29-29, 2014

Efficacy and safety of rituximab as maintenance therapy for relapsing granulomatosis with polyangiitis-a case series.

Knight, A; Hallenberg, H; Baecklund, Eva

Ingår i Clinical Rheumatology, s. 841-848, 2014

• DOI för Efficacy and safety of rituximab as maintenance therapy for relapsing granulomatosis with polyangiitis-a case series.
• Ladda ner fulltext (pdf) av Efficacy and safety of rituximab as maintenance therapy for relapsing granulomatosis with polyangiitis-a case series.

First Results of a European Registries Collaborative Project to Compare the Spectrum of Lymphomas Between Different Exposure Groups in Rheumatoid Arthritis

Mercer, Louise; Mariette, Xavier; Dixon, William; Baecklund, Eva et al.

Ingår i Arthritis & Rheumatology, 2014

Donor or Recipient Origin of Posttransplant Lymphoproliferative Disorders Following Solid Organ Transplantation

Kinch, Amelie; Cavelier, Lucia; Bengtsson, Mats; Baecklund, Eva et al.

Ingår i American Journal of Transplantation, s. 2838-2845, 2014

• DOI för Donor or Recipient Origin of Posttransplant Lymphoproliferative Disorders Following Solid Organ Transplantation

Ro52/TRIM21 Expression is Decreased in Malignant B Cells

Ivanchenko, Margarita; Brauner, Susanna; Enblad, Gunilla; Sundström, Christer et al.

Ingår i Scandinavian Journal of Immunology, s. 453-454, 2014

A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.

Kinch, Amelie; Baecklund, Eva; Backlin, Carin; Ekman, Tor et al.

Ingår i Acta Oncologica, s. 669-679, 2014

• DOI för A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial.

Gabay, Cem; Emery, Paul; van Vollenhoven, Ronald; Dikranian, Ara et al.

Ingår i The Lancet, 2013

• DOI för Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial.

Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden.

Raaschou, Pauline; Simard, Julia F; Holmqvist, Marie; Askling, Johan et al.

Ingår i BMJ (Clinical research ed.), 2013

Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008: A Swedish population-based study

Krynitz, Britta; Edgren, Gustaf; Lindelöf, Bernt; Baecklund, Eva et al.

Ingår i International Journal of Cancer, s. 1429-1438, 2013

• DOI för Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008: A Swedish population-based study

Ro52 Expression is a Prognostic Factor for Survival in B Cell Lymphoma

Brauner, Susanna; Zhou, Wei; Backlin, Carin; Green, Tina M. et al.

Ingår i Annals of the Rheumatic Diseases, 2013

• DOI för Ro52 Expression is a Prognostic Factor for Survival in B Cell Lymphoma

Are Patients With Rheumatoid Arthritis Still At An Increased Risk Of Tuberculosis and What Is The Role Of Biological Treatment?

Arkema, Elizabeth V.; Jonsson, Jerker; Baecklund, Eva; Rutting, Maud et al.

Ingår i Arthritis and Rheumatism, 2013

Lifestyle factors, autoimmune disease and family history in prognosis of non-hodgkin lymphoma overall and subtypes

Simard, Julia F; Baecklund, Fredrik; Chang, Ellen T; Baecklund, Eva et al.

Ingår i International Journal of Cancer, s. 2659-2666, 2013

• DOI för Lifestyle factors, autoimmune disease and family history in prognosis of non-hodgkin lymphoma overall and subtypes

Does Biological Therapy Alter the Lymphoma Risk or Distribution of Lymphoma Subtypes in Patients with ra?

Baecklund, Eva; Hellgren, K.; Sundström, Christer; Askling, J.

Ingår i Annals of the Rheumatic Diseases, s. 427-427, 2013

• DOI för Does Biological Therapy Alter the Lymphoma Risk or Distribution of Lymphoma Subtypes in Patients with ra?

Rheumatoid Arthritis and Risks of Malignant Lymphoma: Are Risks Still Increased?

Hellgren, Karin; Baecklund, Eva; Smedby, Karin E.; Backlin, Carin et al.

Ingår i Arthritis and Rheumatism, 2012

LMO2 protein expression predicts survival in patients with rheumatoid arthritis and diffuse large B-cell lymphoma

Baecklund, Eva; Backlin, Carin; Mansouri, Mahmoud; Klareskog, Lars et al.

Ingår i Leukemia and Lymphoma, s. 1146-1149, 2011

• DOI för LMO2 protein expression predicts survival in patients with rheumatoid arthritis and diffuse large B-cell lymphoma

Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjögren's syndrome

Nordmark, Gunnel; Kristjansdottir, Gudlaug; Theander, E.; Appel, S. et al.

Ingår i Genes and Immunity, s. 100-109, 2011

• DOI för Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjögren's syndrome

Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren's syndrome

Theander, Elke; Vasaitis, Lilian; Baecklund, Eva; Nordmark, Gunnel et al.

Ingår i Annals of the Rheumatic Diseases, s. 1363-1368, 2011

• DOI för Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren's syndrome

Ten years with biologics: to whom do data on effectiveness and safety apply?

Simard, Julia F.; Arkema, Elizabeth V.; Sundström, Anders; Geborek, Pierre et al.

Ingår i Rheumatology, s. 204-213, 2011

• DOI för Ten years with biologics: to whom do data on effectiveness and safety apply?

Pediatric Organ Transplantation and Risk of Premalignant and Malignant Tumors in Sweden

Simard, J. F.; Baecklund, Eva; Kinch, Amelie; Brattström, C. et al.

Ingår i American Journal of Transplantation, s. 146-151, 2011

• DOI för Pediatric Organ Transplantation and Risk of Premalignant and Malignant Tumors in Sweden

Time Trends in Risk and Risk Determinants of Non-Hodgkin Lymphoma in Solid Organ Transplant Recipients

Fernberg, P.; Edgren, G.; Adami, J.; Ingvar, Å. et al.

Ingår i American Journal of Transplantation, s. 2472-2482, 2011

• DOI för Time Trends in Risk and Risk Determinants of Non-Hodgkin Lymphoma in Solid Organ Transplant Recipients

Expression of APRIL in Diffuse Large B Cell Lymphomas from Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis

Löfström, Bjorn; Backlin, Carin; Pettersson, Tom; Lundberg, Ingrid E. et al.

Ingår i Journal of Rheumatology, s. 1891-1897, 2011

• DOI för Expression of APRIL in Diffuse Large B Cell Lymphomas from Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis

Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA Study

Sokka, Tuulikki; Kautiainen, Hannu; Pincus, Theodore; Verstappen, Suzanne M. et al.

Ingår i Arthritis Research & Therapy, 2010

• DOI för Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA Study

Rheumatoid arthritis, treatment with corticosteroids, and risk of malignant lymphomas: results from a case-control study

Hellgren, Karin; Iliadou, Anastasia; Rosenquist, Richard; Feltelius, Nils et al.

Ingår i Annals of the Rheumatic Diseases, s. 654-659, 2010

• DOI för Rheumatoid arthritis, treatment with corticosteroids, and risk of malignant lymphomas: results from a case-control study

Do rheumatoid arthritis and lymphoma share risk factors?: A comparison of lymphoma and cancer risks before and after diagnosis of rheumatoid arthritis

Hellgren, Karin; Smedby, Karin E.; Feltelius, Nils; Baecklund, Eva et al.

Ingår i Arthritis and Rheumatism, s. 1252-1258, 2010

• DOI för Do rheumatoid arthritis and lymphoma share risk factors?: A comparison of lymphoma and cancer risks before and after diagnosis of rheumatoid arthritis

Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database

Sokka, T.; Kautiainen, H.; Pincus, T.; Toloza, S. et al.

Ingår i Annals of the Rheumatic Diseases, s. 1666-1672, 2009

• DOI för Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database

Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register

Askling, Johan; Baecklund, Eva; Granath, F.; Geborek, P. et al.

Ingår i Annals of the Rheumatic Diseases, s. 648-653, 2009

• DOI för Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register

Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?

Askling, Johan; van Vollenhoven, Ronald F.; Granath, Fredrik; Raaschou, Pauline et al.

Ingår i Arthritis and Rheumatism, s. 3180-3189, 2009

• DOI för Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?

Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis

Baecklund, Eva; Natkunam, Yasodha; Backlin, Carin; Iliadou, Anastasia et al.

Ingår i British Journal of Haematology, s. 69-72, 2008

• DOI för Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis

QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries

Sokka, Tuulikki; Kautiainen, Hannu; Toloza, Sergio; Mäkinen, Heidi et al.

Ingår i Annals of the Rheumatic Diseases, s. 1491-1496, 2007

• DOI för QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries

Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists

Askling, Johan; Fored, C. Michael; Brandt, Lena; Baecklund, Eva et al.

Ingår i Annals of the Rheumatic Diseases, s. 1339-1344, 2007

• DOI för Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists

Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis

Baecklund, Eva; Iliadou, Anastasia; Askling, Johan; Ekbom, Anders et al.

Ingår i Arthritis and Rheumatism, s. 692-701, 2006

• DOI för Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis

Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis

Baecklund, Eva; Backlin, Carin; Iliadou, Anastasia; Granath, Fredrik et al.

Ingår i Arthritis and Rheumatism, s. 3774-3781, 2006

• DOI för Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis

Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics

Smedby, Karin Ekström; Baecklund, Eva; Askling, Johan

Ingår i Cancer Epidemiology, Biomarkers and Prevention, s. 2069-2077, 2006

• DOI för Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics

Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists

Askling, J; Fored, C M; Brandt, L; Baecklund, Eva et al.

Ingår i Annals of the Rheumatic Diseases, s. 1421-1426, 2005

• DOI för Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists

Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis

Askling, J; Klareskog, L; Hjalgrim, H; Baecklund, Eva et al.

Ingår i Annals of the Rheumatic Diseases, s. 1765-1768, 2005

• DOI för Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis

Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists

Askling, J; Fored, C M; Baecklund, Eva; Brandt, L et al.

Ingår i Annals of the Rheumatic Diseases, s. 1414-1420, 2005

• DOI för Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists

Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden

Askling, Johan; Fored, C. Michael; Brandt, Lena; Baecklund, Eva et al.

Ingår i Arthritis and Rheumatism, s. 1986-1992, 2005

• DOI för Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden

Rheumatoid arthritis and malignant lymphomas

Baecklund, Eva; Askling, Johan; Rosenquist, Richard; Ekbom, Anders et al.

Ingår i Current Opinion in Rheumatology, s. 254-261, 2004

Single-tube nested quantitative PCR: a rational and sensitive technique for detection of retroviral DNA. Application to RERV-H/HRV-5 and confirmation of its rabbit origin

Forsman, Anna; Uzameckis, Dmitrijs; Rönnblom, Lars; Baecklund, Eva et al.

Ingår i Journal of Virological Methods, s. 1-11, 2003

• DOI för Single-tube nested quantitative PCR: a rational and sensitive technique for detection of retroviral DNA. Application to RERV-H/HRV-5 and confirmation of its rabbit origin

Lymphoma subtypes in patients with rheumatoid arthritis: Increased proportion of diffuse large B cell lymphoma

Baecklund, Eva; Sundström, Christer; Ekbom, Anders; Catrina, Anca et al.

Ingår i Arthritis & Rheumatism, s. 1543-1550, 2003

Decreasing mortality in patients with rheumatoid arthrithis: results from large population based cohort in Sweden 1964-95

Björnådal, Lena; Baecklund, Eva; Yin, Li; Granath, Fredrik et al.

Ingår i Journal of Rheumatology, s. 906-912, 2002

Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study

Baecklund, Eva; Ekbom, Anders; Sparén, Pär; Feltelius, Nils et al.

Ingår i British Medical Journal, s. 180-181, 1998

Lymphoma development in patients with autoimmune and inflammatory disorders: What are the driving forces?

Baecklund, Eva; Smedby, Karin E.; Sutton, Lesley-Ann; Askling, Johan et al.

Ingår i Seminars in Cancer Biology, s. 61-70, 2014

• DOI för Lymphoma development in patients with autoimmune and inflammatory disorders: What are the driving forces?

Autoimmune and inflammatory disorders and risk of malignant lymphomas: an update

Smedby, K. E.; Askling, J.; Mariette, X.; Baecklund, Eva

Ingår i Journal of Internal Medicine, s. 514-527, 2008

• DOI för Autoimmune and inflammatory disorders and risk of malignant lymphomas: an update

Diffuse large B-cell lymphomas in rheumatoid arthritis display a predominance of non-germinal center type

Baecklund, Eva; Backlin, Carin; Iliadou, Anastasia; Granath, Fredrik et al.